Reid Hoffman's ambitious new venture in cancer treatment

Reid Hoffman, co-founder of LinkedIn, launches a healthcare startup called Manas AI to innovate cancer treatment. Manas AI, co-founded with Dr. Siddhartha Mukherjee, focuses on using artificial intelligence to improve drug development processes. The startup targets aggressive cancers, including breast, prostate, and lymphoma, aiming to accelerate drug discovery and understanding of drug interactions with the human body. Manas AI secured $24.6 million in seed funding, with contributions from General Catalyst and will utilize Microsoft’s data centers. Dr. Mukherjee, a professor at Columbia University, leads the integration of AI and biological sciences alongside Hoffman. The healthcare AI sector saw $10.5 billion in investments across various deals in 2024.Learn more on this news visit us at: https://greyjournal.net/ Hosted on Acast. See acast.com/privacy for more information.